חיפוש מתקדם
eMed Innovation
הרצאות - e-Media
Epocrates
Journal Club
נקודות השתלמות - CME
מרכזי מידע ושירות
בתי"ס אינטרנטיים
עדכון עלוני תרופות
דרושים
Facebook
מידע למפרסם
מאגר תרופות משה"ב
אינדקס רופאים
אינדקס שימושי
חדשות משה"ב
eMed Health Club
MESS - מחקרים
ADR - תופעות לוואי
הרפואה בקולנוע
השבוע ברפואה
הומור רפואי
מחקרים קליניים בישראל
DDX
e-Med Tools
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
e-MedCase
אנו שמחים להזמינכם לקורס נוסף שיזם החוג לאי ספיקת לב בנושא חשוב ביותר – ניהול הטיפול באי ספיקת לב...jpg)
שמחנו לגלות באמצעות אתר משה"ב שקיים מאגר מחקרים בינ"ל המאפשר הצגה של מחקרים קליניים המתקיימים בישראל. אנו מאמינים שמידע זמין ועדכני של מחקרים קליניים יאפשר לציבור הרופאים להפנות מטופלים מתאימים למחקרים רלבנטים, ואף יהווה ערוץ שבו מטופלים מתאימים יוכלו להציע עצמם למחקרים שמעוניינים בגיוס משתתפים, ושהם עונים לקריטריונים.
לכניסה למאגר המחקרים (המנוהלים בישראל ואשר נמצאים בשלב גיוס או טרום גיוס של חולים)
נכון לכתיבת שורות אלה היו 258 מחקרים כאלה במאגר.
ניתן לבצע במאגר חיפוש בהתאם לסוגי מחלות, התערבויות כדי לצמצם את החיפוש לקריטריונים הרלבנטים. למשל, חיפוש בתוך המאגר של מחקרים בתחום הסרטן מניב את הרשימה של 39 המחקרים שלהלן.
| Include studies which are not seeking new volunteers. |
| 1 | Recruiting | Peritumoral Injection of Immature Dendritic Cells to Irradiated Skin Metastases of Solid Tumors | ||||
| Conditions: | Cancer of Skin; Solid Tumors | |||||
| Intervention: | Procedure: Immunotherapy treatment for solid tumors | |||||
| 2 | Recruiting | Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole | ||||
| Condition: | Breast Cancer | |||||
| Intervention: | Drug: zoledronic acid | |||||
| 3 | Recruiting | Gemcitabine With Curcumin for Pancreatic Cancer | ||||
| Condition: | Pancreatic Cancer | |||||
| Intervention: | Drug: curcumin (+ gemcitabine) | |||||
| 4 | Not yet recruiting | Development of Gourmet Healthy Cooking Workshop for Cancer Patients | ||||
| Condition: | Breast Cancer | |||||
| Intervention: | Behavioral: gourment cooking workshop | |||||
| 5 | Recruiting | Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host | ||||
| Conditions: | Hematological Malignancy; Neoplasm Metastasis | |||||
| Intervention: | Procedure: DLI sensitized against antigens expressed by the host. | |||||
| 6 | Recruiting | Mistletoe as Complementary Treatment in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination: Randomized Phase II Study | ||||
| Condition: | Non Small Cell Lung Cancer | |||||
| Intervention: | Drug: Mistletoe extract | |||||
| 7 | Recruiting | Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients | ||||
| Condition: | Hormone Refractory Prostate Cancer | |||||
| Intervention: | Drug: Fermented Wheat germ extract | |||||
| 8 | Recruiting | Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer | ||||
| Condition: | Stomach Neoplasms | |||||
| Interventions: | Procedure: Chemotherapy; Procedure: surgery; Procedure: radiotherapy | |||||
| 9 | Not yet recruiting | A Novel Vaccine for the Treatment of MUC1-Expressing Tumor Malignancies | ||||
| Conditions: | Multiple Myeloma; Tumors | |||||
| Intervention: | Biological: Peptide Vaccine (MUC-1) | |||||
| 10 | Recruiting | Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer | ||||
| Condition: | Non-Small Cell Lung Cancer | |||||
| Intervention: | Drug: chemotherapy +/- disulfiram | |||||
| 11 | Not yet recruiting | Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer | ||||
| Condition: | Colon Neoplasm | |||||
| Interventions: | Drug: CELECOXIB; Drug: CURCUMIN | |||||
| 12 | Recruiting | Newcastle Disease Virus (NDV) for Cancer Patients Resistant to Conventional Anti-Cancer Modalities | ||||
| Conditions: | Metastatic Cancer; Newcastle Disease Virus (NDV) | |||||
| Intervention: | Procedure: Newcastle Virus | |||||
| 13 | Recruiting | The Effect of Cognitive Behavior Intervention on Psychological Distress of Cancer Patients and Their Family Members | ||||
| Condition: | Cancer | |||||
| Intervention: | Behavioral: cognitive-behavior groups | |||||
| 14 | Recruiting | Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer | ||||
| Condition: | Pancreatic Cancer | |||||
| Interventions: | Drug: Gemcitabine; Drug: Curcumin; Drug: Celebrex | |||||
| 15 | Recruiting | Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid Tumors | ||||
| Condition: | Tumors | |||||
| Intervention: | Procedure: Cell therapy | |||||
| 16 | Recruiting | Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors | ||||
| Condition: | Metastatic Solid Tumors | |||||
| Intervention: | Biological: Tumor Cell Vaccine | |||||
| 17 | Recruiting | Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC | ||||
| Conditions: | Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | |||||
| Intervention: | Drug: Erlotinib, Temozolomide | |||||
| 18 | Not yet recruiting | Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-Colectomy | ||||
| Condition: | Colon Cancer | |||||
| Intervention: | Device: LapCAC Laparoscopic Compression Anastomosis Clip | |||||
| 19 | Recruiting | Concurrent Xeloda and Radiotherapy for Bone Metastases | ||||
| Conditions: | Solid Tumors; Bone Metastases | |||||
| Interventions: | Drug: Xeloda; Procedure: External Beam Radiotherapy | |||||
| 20 | Recruiting | Immunotherapy of Cancer Using Donor Lymphocytes Labelled With in-Vitro Bispecific Antibodies. | ||||
| Condition: | Metastatic Solid Tumors | |||||
| Intervention: | Drug: Cell therapy with bispecific antibodies | |||||
| 21 | Recruiting | Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma | ||||
| Condition: | Breast Neoplasms | |||||
| Intervention: | Drug: cetuximab paclitaxel | |||||
| 22 | Not yet recruiting | Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia | ||||
| Condition: | Chronic Myeloid Leukemia | |||||
| Intervention: | Biological: Allogeneic tumor cell vaccine | |||||
| 23 | Recruiting | Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain | ||||
| Conditions: | Ulcer; Wounds and Injuries | |||||
| Intervention: | Drug: topical morphine | |||||
| 24 | Recruiting | Immunochemotherapy for Metastatic Renal Cell Carcinoma | ||||
| Condition: | Adenocarcinoma Clear Cell | |||||
| Intervention: | Drug: Capecitabine (Xeloda) | |||||
| 25 | Not yet recruiting | Tocopherol is a Novel Treatment for Cancer Related Mucositis | ||||
| Condition: | Oral Mucositis | |||||
| Intervention: | Drug: Tocopherol | |||||
| 26 | Recruiting | The Role of Peptide-Loaded Dendritic Cells to Augment the Therapeutic Effect of Interleukin-2 | ||||
| Condition: | Metastatic Melanoma | |||||
| Intervention: | Procedure: Immunotherapy treatment for melanoma | |||||
| 27 | Recruiting | Adoptive Cell Therapy Following Non-Myeloablate Chemotherapy in Metastatic Melanoma Patients | ||||
| Condition: | Metastatic Melanoma | |||||
| Intervention: | Procedure: Procedure - Adoptive cell transfer | |||||
| 28 | Not yet recruiting | EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children | ||||
| Condition: | Rhabdomyosarcoma | |||||
| Intervention: | Drug: doxorubicin, cytoxan | |||||
| 29 | Not yet recruiting | Zevalin and BEAM High-Dose Chemotherapy Compared With BEAM Alone as Conditioning Regimen in Patients With Chemosensitive Relapse of Non-Hodgkin’s Lymphoma | ||||
| Condition: | Non-Hodgkin’s Lymphoma | |||||
| Intervention: | Drug: 90Yttrium Ibritumomab Tiuxetan (Zevalin) | |||||
| 30 | Recruiting | Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision. | ||||
| Condition: | Hodgkin Lymphoma | |||||
| Intervention: | Procedure: interim PET/CT | |||||
| 31 | Recruiting | To Determine the Role of Adding Campath-1H or ATG Given in-Vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning | ||||
| Conditions: | Acute Myeloid Leukemia; Myelodysplastic Syndrome | |||||
| Intervention: | Drug: Campath-1H /ATG | |||||
| 32 | Recruiting | Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy | ||||
| Condition: | Leukemia, Myeloid, Philadelphia-Positive | |||||
| Intervention: | Drug: Pegylated Interferon and Imatinib | |||||
| 33 | Recruiting | Zevalin-Beam for Aggressive Lymphoma | ||||
| Condition: | Non-Hodgkin's Lymphoma | |||||
| Intervention: | Drug: ibritumomab tiuxetan (zevalin) | |||||
| 34 | Recruiting | Treosulfan-Based Conditioning for Transplantation in AML/MDS | ||||
| Conditions: | Acute Myeloid Leukemia; Myelodysplastic Syndrome | |||||
| Intervention: | Drug: treosulfan | |||||
| 35 | Not yet recruiting | Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients | ||||
| Conditions: | Multiple Myeloma; Newly Diagnosed Patients | |||||
| Interventions: | Drug: Melphalan; Drug: Lenalidomide | |||||
| 36 | Recruiting | Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation | ||||
| Conditions: | Myelodysplastic Syndromes; Myelofibrosis | |||||
| Intervention: | Device: DBM for creation of bone marrow microenvironment | |||||
| 37 | Recruiting | 18FDG- PET/CT Contribution to the Assessment of Lesion Severity in Cystic Fibrosis (CF) | ||||
| Condition: | Cystic Fibrosis | |||||
| Intervention: | Procedure: PET-CT | |||||
| 38 | Not yet recruiting | Evaluation the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic Syndrome Patients With Iron Over Load | ||||
| Condition: | Myelodysplastic Syndrome | |||||
| Intervention: | Drug: Exjade | |||||
| 39 | Recruiting | In Vitro Maturation of Immature Oocytes | ||||
| Conditions: | Polycystic Ovary Syndrome; Ovarian Hyperstimulation Syndrome | |||||
| Intervention: | Procedure: In Vitro Maturation of immature oocytes | |||||